Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Anzupgo“
Suchtreffer
Begriffe & Kennungen
Anzupgo
Eintrag öffnenAnzupgo · 4.1 Therapeutic indications · 1
Eintrag öffnenAnzupgo · 4.3 Contraindications · 1
Eintrag öffnenAnzupgo · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAnzupgo · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenAnzupgo · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenAnzupgo · 4.5 · Delgocitinib has not been evaluated in combination with other topical medicinal products and co- application o
Eintrag öffnenAnzupgo · 4.5 · No clinical interaction studies have been performed with topically or systemically administered delgocitinib (
Eintrag öffnenAnzupgo · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenAnzupgo · 4.8 Undesirable effects · 1
Eintrag öffnenAnzupgo · 4.8 · 4 Tabulated list of adverse reactions
Eintrag öffnenAnzupgo · 4.8 · Application site reactions In the pool of three vehicle-controlled clinical studies through 16 weeks, 9 applic
Eintrag öffnenAnzupgo · 4.8 · Description of selected adverse reactions
Eintrag öffnenAnzupgo · 4.8 · Paediatric population
Eintrag öffnenAnzupgo · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenAnzupgo · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenAnzupgo · 4.8 · Summary of the safety profile
Eintrag öffnenAnzupgo · 4.8 · Table 1 Adverse reactions System Organ Class Frequency Adverse reaction General disorders and Common Applicati
Eintrag öffnenAnzupgo · 4.8 · Table 1 lists the adverse reactions that were observed in clinical studies. The adverse reactions are presente
Eintrag öffnenAnzupgo · 4.8 · The event rate of application site reactions in the long-term extension study (0.56 events per 100 patient yea
Eintrag öffnen